arrow_back Back to App

Increased Access to Opioid Overdose Reversal Medication

This act aims to increase the availability of opioid overdose reversal medications, such as naloxone. It makes it easier for citizens to access these life-saving drugs in emergencies. It also boosts funding for education and distribution programs.
Key points
Expands grant programs to allow more entities (not just states) to receive funds for medication access and education.
Encourages healthcare providers to co-prescribe opioid overdose reversal medications with opioid prescriptions when appropriate.
Supports innovative community-based distribution programs, making it easier to obtain these medications.
Increases funding for these programs from $5 million to $10 million annually for fiscal years 2023-2027.
Requires at least 20% of grants to offset costs for distributing and dispensing medications, reducing financial barriers for citizens.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_4794
Sponsor: Sen. Baldwin, Tammy [D-WI]
Process start date: 2022-09-07
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Naloxone Education and Access Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_4794.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-09-07.

What are the main provisions?

Key points include:

  • Expands grant programs to allow more entities (not just states) to receive funds for medication access and education.
  • Encourages healthcare providers to co-prescribe opioid overdose reversal medications with opioid prescriptions when appropriate.
  • Supports innovative community-based distribution programs, making it easier to obtain these medications.
  • Increases funding for these programs from $5 million to $10 million annually for fiscal years 2023-2027.
  • Requires at least 20% of grants to offset costs for distributing and dispensing medications, reducing financial barriers for citizens.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Baldwin, Tammy [D-WI].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health